DENTSPLY SIRONA Inc. (XRAY) Stock Forecast
Data as of Jun 16, 2026Healthcare · Current price $10.53 (+3.90%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Feb 3, 2026 | Kevin Caliendo | UBS | $16.00 | +52.0% |
| Oct 8, 2025 | Elizabeth Anderson | Evercore ISI | $13.00 | +23.5% |
| Aug 8, 2025 | Michael Petusky | Barrington | $18.00 | +71.0% |
| Apr 15, 2025 | Erin Wright | Morgan Stanley | $14.00 | +33.0% |
| Jan 23, 2025 | Glen Santangelo | Jefferies | $20.00 | +90.0% |
| Jul 22, 2024 | Jeff Johnson | Robert W. Baird | $31.00 | +194.5% |
| Jul 18, 2024 | Jonathan Block | Stifel Nicolaus | $28.00 | +166.0% |
| May 3, 2024 | Jason Bednar | Piper Sandler | $32.00 | +204.0% |
| Nov 16, 2023 | David Saxon | Needham | $35.00 | +232.5% |
| Jun 1, 2022 | Kevin Caliendo | UBS | $47.00 | +346.6% |
| Apr 19, 2022 | Jeffrey Johnson | Robert W. Baird | $48.00 | +356.1% |
| Nov 4, 2021 | Jonathan Block | Stifel Nicolaus | $60.00 | +470.1% |
| Aug 6, 2021 | Jason Bednar | Piper Sandler | $75.00 | +612.6% |
Top Analysts Covering XRAY
XRAY vs Sector & Market
| Metric | XRAY | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.64 | 2.24 | 2.40 |
| Analyst Count | 11 | 8 | 19 |
| Target Upside | +28.1% | +11475.0% | +17.1% |
| P/E Ratio | -3.93 | 3.91 | 31.64 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $3.53B | $3.58B | $3.61B | 14 |
| 2027-03-31 | $850M | $861M | $876M | 5 |
| 2027-06-30 | $903M | $914M | $930M | 6 |
| 2027-09-30 | $887M | $899M | $914M | 9 |
| 2027-12-31 | $968M | $980M | $997M | 5 |
| 2028-03-31 | $890M | $902M | $917M | 4 |
| 2028-06-30 | $941M | $953M | $970M | 6 |
| 2028-09-30 | $928M | $940M | $955M | 9 |
| 2028-12-31 | $996M | $1.01B | $1.03B | 4 |
| 2029-12-31 | $3.73B | $3.78B | $3.84B | 11 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $1.40 | $1.43 | $1.46 | 12 |
| 2027-03-31 | $0.33 | $0.33 | $0.34 | 4 |
| 2027-06-30 | $0.40 | $0.41 | $0.42 | 5 |
| 2027-09-30 | $0.38 | $0.39 | $0.39 | 8 |
| 2027-12-31 | $0.42 | $0.42 | $0.43 | 4 |
| 2028-03-31 | $0.33 | $0.34 | $0.35 | 5 |
| 2028-06-30 | $0.39 | $0.40 | $0.41 | 7 |
| 2028-09-30 | $0.43 | $0.43 | $0.44 | 10 |
| 2028-12-31 | $0.56 | $0.57 | $0.58 | 5 |
| 2029-12-31 | $1.73 | $1.76 | $1.80 | 1 |
Frequently Asked Questions
What is the analyst consensus for XRAY?
The consensus among 11 analysts covering DENTSPLY SIRONA Inc. (XRAY) is Hold with an average price target of $13.40.
What is the highest price target for XRAY?
The highest price target for XRAY is $75.00, set by Jason Bednar at Piper Sandler on 2021-08-06.
What is the lowest price target for XRAY?
The lowest price target for XRAY is $13.00, set by Elizabeth Anderson at Evercore ISI on 2025-10-08.
How many analysts cover XRAY?
11 analysts have issued ratings for DENTSPLY SIRONA Inc. in the past 12 months.
Is XRAY a buy or sell right now?
Based on 11 analyst ratings, XRAY has a consensus rating of Hold (2.64/5) with a +28.1% upside to the consensus target of $13.40.
What are the earnings estimates for XRAY?
Analysts estimate XRAY will report EPS of $1.43 for the period ending 2026-12-31, with revenue estimated at $3.58B.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.